News & Events about Unity Biotechnology Inc.
SOUTH SAN FRANCISCO, Calif., Jan. 18, 2023 (GLOBE NEWSWIRE) -- UNITY Biotechnology, Inc. (UNITY) [NASDAQ: UBX], a biotechnology company developing therapeutics to slow, halt, or reverse diseases of aging, today announced that from January 3, 2023, through January 17, 2023, the Compensation Committee...
Thinking about buying stock in Atlas Corp, Unity Biotechnology, Abiomed, Tilray, or Pfizer? Thinking about buying stock in Atlas Corp, Unity Biotechnology, Abiomed, Tilray, or Pfizer? PR Newswire NEW YORK, Nov. 1, 2022 NEW YORK, Nov. 1, 2022 /PRNewswire/ --InvestorsObserverissues critical...
Globe Newswire
3 months ago
UBX common stock expected to begin trading on a split-adjusted basis on October20, 2022SOUTH SAN FRANCISCO, Calif., Oct. 19, 2022 (GLOBE NEWSWIRE) -- UNITY Biotechnology, Inc. (UNITY or the Company) (Nasdaq:UBX), a biotechnology company developing therapeutics to slow, halt or reverse diseases of ...
Globe Newswire
5 months ago
SOUTH SAN FRANCISCO, Calif., Aug. 31, 2022 (GLOBE NEWSWIRE) -- UNITY Biotechnology, Inc. (Nasdaq: UBX), a biotechnology company developing therapeutics to slow, halt, or reverse diseases of aging, today announced that members of its senior management team will participate in the following investor ...
Globe Newswire
5 months ago
SOUTH SAN FRANCISCO, Calif., Aug. 17, 2022 (GLOBE NEWSWIRE) -- UNITY Biotechnology, Inc. (UNITY) (Nasdaq:UBX), a biotechnology company developing therapeutics to slow, halt, or reverse diseases of aging, today announced the pricing of an upsized underwritten public offering of 64,285,714 shares of ...